SCHEMBL21987985

SCHEMBL21987985

Cc1noc2c1C(=O)NCC2

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 4/20 0.54
CDC7 O00311 2/20 0.36
RIPK3 Q9Y572 4/20 0.35
HTR2C P28335 2/20 0.32
HTR2A P28223 2/20 0.32
HTR1D P28221 1/20 0.32
HTR1E P28566 1/20 0.32
HTR7 P34969 1/20 0.32
HTR2B P41595 1/20 0.32
HTR3A P46098 1/20 0.32
HTR5A P47898 1/20 0.32
HTR6 P50406 1/20 0.32
PARP10 Q53GL7 4/20 0.32
PARP11 Q9NR21 3/20 0.32
PARP1 P09874 2/20 0.32
CRBN Q96SW2 1/20 0.31
HTR1A P08908 1/20 0.31
DRD2 P14416 1/20 0.31
CHRM3 P20309 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13145564 0.72 BRD4 (0.41) BRD4HTR2CHTR2AHTR1ADRD2
SCHEMBL3131565 0.69 SMN1; SMN2 (0.42) BRD4HTR2AHTR1ADRD2
SCHEMBL9024849 0.69 SMN1; SMN2 (0.42) BRD4HTR2AHTR1ADRD2
SCHEMBL16738107 0.68 BRD4 (0.66) BRD4HTR2CHTR2AHTR1DHTR1E
SCHEMBL20499686 0.67 EZH2 (0.53) BRD4
SCHEMBL21614780 0.65 BRD4 (0.41) BRD4
SCHEMBL29738463 0.64 CDC7 (0.43) CDC7PARP10PARP11PARP1CRBN
SCHEMBL21987941 0.63 CDC7 (0.36) CDC7HTR2APARP10PARP11PARP1
SCHEMBL34469201 0.63 BRD4 (0.40) BRD4HTR2CHTR2AHTR1DHTR1E
SCHEMBL19154250 0.62 LRRK2 (0.39) BRD4CDC7PARP10PARP11PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112424195-B Fused lactam derivatives 住友制药株式会社 2025-03-25 CN disclosed
US-20250084090-A1 SUBSTITUTED LACTAMS SHOWING SEROTONIN 5-HT RECEPTOR ACTIVITY Sumitomo Pharma Co., Ltd. (JP) 2025-03-13 US disclosed
US-12180213-B2 Substituted pyrazoles showing serotonin 5-HT receptor activity SUMITOMO PHARMA CO. LTD. (JP) 2024-12-31 US disclosed
US-20230008875-A1 SUBSTITUTED LACTAMS SHOWING SEROTONIN 5-HT RECEPTOR ACTIVITY Sumitomo Pharma Co., Ltd. (JP) 2023-01-12 US disclosed
US-11466007-B2 Substituted lactams showing serotonin 5-HT receptor activity Sumitomo Pharma Co., Ltd. (JP) 2022-10-11 US disclosed
EP-3828182-A1 FUSED RING LACTAM DERIVATIVES Sumitomo Dainippon Pharma Co., Ltd. (JP) 2021-06-02 EP disclosed
US-10745401-B2 Condensed lactam derivative SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2020-08-18 US disclosed
US-20200255432-A1 CONDENSED LACTAM DERIVATIVE SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2020-08-13 US disclosed
US-20200172543-A1 CONDENSED LACTAM DERIVATIVE SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2020-06-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200255432-A1 CONDENSED LACTAM DERIVATIVE PSEN1, GRIN1, HDAC1 BRD4 119/4885CDC7 3245/4885RIPK3 2800/4885
US-20250084090-A1 SUBSTITUTED LACTAMS SHOWING SEROTONIN 5-HT RECEPTOR ACTIVITY HTR1A, HTR5A, TPH1 BRD4 2127/4885CDC7 4200/4885RIPK3 2295/4885
US-12180213-B2 Substituted pyrazoles showing serotonin 5-HT receptor activity HTR5A, HTR1A, TPH1 BRD4 1218/4885CDC7 4573/4885RIPK3 1290/4885
US-10745401-B2 Condensed lactam derivative PSEN1, GRIN1, HDAC1 BRD4 119/4885CDC7 3245/4885RIPK3 2800/4885
US-11466007-B2 Substituted lactams showing serotonin 5-HT receptor activity HTR1A, HTR5A, TPH1 BRD4 2127/4885CDC7 4200/4885RIPK3 2295/4885
US-20230008875-A1 SUBSTITUTED LACTAMS SHOWING SEROTONIN 5-HT RECEPTOR ACTIVITY HTR1A, HTR5A, TPH1 BRD4 2127/4885CDC7 4200/4885RIPK3 2295/4885
US-20200172543-A1 CONDENSED LACTAM DERIVATIVE PSEN1, GRIN1, HDAC1 BRD4 119/4885CDC7 3245/4885RIPK3 2800/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.